BUSINESSDr Reddy’s Acquires Mayne Pharma’s USA Prescription Portfolio for $105 MillionadminFebruary 27, 2023February 27, 2023 February 27, 2023February 27, 2023 Dr Reddy’s Laboratories (DRL) has entered into a definitive agreement to acquire Australia-based Mayne Pharma Group’s US generic for an upfront payment of $90 million...